Temporal and spatial dynamics underlying capacitative calcium entry in human colonic smooth muscle

Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G88-98. doi: 10.1152/ajpgi.00305.2007. Epub 2007 Nov 1.

Abstract

Following smooth muscle excitation and contraction, depletion of intracellular Ca(2+) stores activates capacitative Ca(2+) entry (CCE) to replenish stores and sustain cytoplasmic Ca(2+) (Ca(2+)(i)) elevations. The objectives of the present study were to characterize CCE and the Ca(2+)(i) dynamics underlying human colonic smooth muscle contraction by using tension recordings, fluorescent Ca(2+)-indicator dyes, and patch-clamp electrophysiology. The neurotransmitter acetylcholine (ACh) contracted tissue strips and, in freshly isolated colonic smooth muscle cells (SMCs), caused elevation of Ca(2+)(i) as well as activation of nonselective cation currents. To deplete Ca(2+)(i) stores, the sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) inhibitors thapsigargin and cyclopiazonic acid were added to a Ca(2+)-free bathing solution. Under these conditions, addition of extracellular Ca(2+) (3 mM) elicited increased tension that was inhibited by the cation channel blockers SKF-96365 (10 microM) and lanthanum (100 microM), suggestive of CCE. In a separate series of experiments on isolated SMCs, SERCA inhibition generated a gradual and sustained inward current. When combined with high-speed Ca(2+)-imaging techniques, the CCE-evoked rise of Ca(2+)(i) was associated with inward currents carrying Ca(2+) that were inhibited by SKF-96365. Regional specializations in Ca(2+) influx and handling during CCE were observed. Distinct "hotspot" regions of Ca(2+) rise and plateau were evident in 70% of cells, a feature not previously recognized in smooth muscle. We propose that store-operated Ca(2+) entry occurs in hotspots contributing to localized Ca(2+) elevations in human colonic smooth muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Aged
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Calcium Signaling* / drug effects
  • Calcium-Transporting ATPases / antagonists & inhibitors
  • Calcium-Transporting ATPases / metabolism
  • Cholinergic Agents / pharmacology
  • Colon / drug effects
  • Colon / enzymology
  • Colon / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Imidazoles / pharmacology
  • Indoles / pharmacology
  • Lanthanum / pharmacology
  • Male
  • Membrane Potentials
  • Microscopy, Fluorescence
  • Muscle Contraction* / drug effects
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / enzymology
  • Muscle, Smooth / metabolism*
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / enzymology
  • Myocytes, Smooth Muscle / metabolism*
  • Patch-Clamp Techniques
  • Thapsigargin / pharmacology
  • Time Factors

Substances

  • Calcium Channel Blockers
  • Cholinergic Agents
  • Enzyme Inhibitors
  • Imidazoles
  • Indoles
  • Thapsigargin
  • Lanthanum
  • Calcium-Transporting ATPases
  • 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole
  • Acetylcholine
  • Calcium
  • cyclopiazonic acid